Short Interest in Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:RVPHW) Increases By 234.8%

Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:RVPHW) was the target of a large growth in short interest in March. As of March 15th, there was short interest totalling 7,700 shares, a growth of 234.8% from the February 28th total of 2,300 shares. Based on an average daily trading volume, of 38,800 shares, the short-interest ratio is currently 0.2 days.

Reviva Pharmaceuticals Stock Performance

Shares of Reviva Pharmaceuticals stock traded down $0.00 during trading hours on Friday, reaching $0.05. The company’s stock had a trading volume of 6,003 shares, compared to its average volume of 25,095. Reviva Pharmaceuticals has a one year low of $0.04 and a one year high of $0.78. The firm has a 50 day moving average price of $0.13 and a 200-day moving average price of $0.16.

About Reviva Pharmaceuticals

Reviva Pharmaceuticals Holdings, Inc, a clinical-stage biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, cardiovascular, metabolic, and inflammatory diseases. The company's lead product candidate is brilaroxazine (RP5063), which is in Phase III clinical trials for use in the treatment of schizophrenia, as well as completed Phase I clinical trials to treat bipolar disorder, major depressive disorder, attentiondeficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease, Parkinson's disease psychosis, attention deficit hyperactivity disorder, pulmonary arterial hypertension, and idiopathic pulmonary fibrosis.